Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene. 2010 Oct 14;29(41):5545-55. doi: 10.1038/onc.2010.323. Epub 2010 Aug 9.
The treatment of cancer is being revolutionized by an improved understanding of the genetic events that occur in tumors. Advances in the understanding of the prevalence and patterns of mutations in melanoma have recently led to impressive results in trials of personalized, targeted therapies for this disease. In this review, we will discuss the molecular targets that have been validated clinically, additional genetic events that are candidates for future trials, and the challenges that remain to improve outcomes further in this aggressive disease.
通过对肿瘤中发生的遗传事件的深入了解，癌症的治疗正在发生革命性的变化。最近，对黑色素瘤中突变的普遍性和模式的认识的提高，导致了针对这种疾病的个体化靶向治疗试验中令人瞩目的结果。在这篇综述中，我们将讨论已经在临床上得到验证的分子靶点、有潜力成为未来试验候选的其他遗传事件，以及在这种侵袭性疾病中进一步提高治疗效果所面临的挑战。
